NEW YORK — For investors who loaded up on biotech last quarter, the melanoma data from Moderna Inc. arrived like a confirmation. For those who trusted DICK’S Sporting Goods to absorb the Foot Locker acquisition without breaking a sweat, it arrived like an invoice.
The S&P 500 gained 24.39 points, or 0.32 percent, to close at 7,677.25 on Tuesday, trading between a session low of 7,650.92 and a high of 7,686.11. The Nasdaq Composite climbed 0.57 percent, with technology and healthcare leading. Year to date the benchmark index has returned 12.15 percent and gained 19.23 percent over the past twelve months. Volume came in at roughly 942 million shares, lighter than the daily average, suggesting conviction behind the session’s gains was narrow.
Moderna Inc. (MRNA) surged 13.89 percent to $158.18, the session’s largest advance among S&P 500 constituents. The catalyst was positive Phase 3 trial data for intismeran autogene, a personalized melanoma vaccine developed with Merck and Co. The results represent the first late-stage clinical proof of concept for mRNA technology applied to oncology, a milestone that validates a research thesis Moderna has been building since its Covid-19 vaccine established the delivery mechanism. Analyst upgrades followed the data release. The company’s year-to-date gain stands at approximately 392 percent, a number that reflects a market recalibrating upward around the potential scale of mRNA in cancer care.
The session’s worst performer was DICK’S Sporting Goods (DKS), which fell 29.13 percent to $127.10 on volume of 22.4 million shares. The retailer reported second-quarter earnings that missed both profit and revenue estimates and cut its full-year guidance. The deeper concern was the Foot Locker acquisition completed in September 2025: integration has underperformed expectations, and same-store sales metrics signaled weakness in core retail operations that predates the deal. JPMorgan maintained an Overweight rating but lowered its price target from $270 to $245 the day before the earnings release, a preemptive move that proved insufficient against the scale of the miss.
The session’s macro shadow is Jackson Hole. Federal Reserve Chair Kevin Warsh is scheduled to deliver remarks at the annual Economic Symposium in Wyoming on Friday. When his nomination was announced in February, gold fell ten percent in a single session on expectations that Warsh would run a tighter monetary policy than his predecessor. Markets have since stopped pricing him as the defining variable in each session’s move. Whether Friday’s remarks reintroduce that uncertainty is the question that neither equity bulls nor fixed-income traders have resolved. Gold prices hit a 15-week high into the speech, with spot gold settling near $4,641 an ounce, a price level that reads less as confidence in rate cuts and more as insurance against whatever he says.
The broader trade backdrop added pressure. Canada announced retaliatory steel duties on $20 billion in goods following Trump administration tariffs. The White House signaled possible tariff increases on autos, trucks, and metals to 50 percent. Walmart Inc. reported billions in tariff refunds in its most recent results, but the gains came alongside slower sales growth: the retailer collecting a windfall from trade policy while its underlying consumer shows strain. The national debt has crossed $40 trillion. Treasury yields remain elevated, complicating the calculus for rate-sensitive sectors and contributing to the light volume that characterized Tuesday’s session.
The earnings backdrop for the index itself is more constructive. The S&P 500 is on track for its strongest earnings growth in years, a performance concentrated in a handful of large-cap technology companies. Alphabet Inc. and Amazon.com Inc. have been doing much of the aggregate heavy lifting, according to Fortune, a structural condition that has drawn consistent commentary from analysts who note that an earnings surge led by two names is simultaneously impressive and fragile. The gold rate today in India and globally reflects the same tension, an asset pricing geopolitical and monetary risk rather than macroeconomic confidence.
Among Tuesday’s other notable movers: Super Micro Computer Inc. (SMCI) gained 8.87 percent, Robinhood Markets Inc. (HOOD) advanced 7.19 percent, CDW Corp. (CDW) rose 6.67 percent, and Bloom Energy Corp. (BE) added 6.09 percent. On the downside, Liberty Global Ltd. (LBTYB) fell 6.00 percent, Beta Technologies (BETA) declined 5.73 percent, Albemarle Corp. (ALB) lost 5.19 percent, and Rubrik Inc. (RBRK) gave up 4.93 percent. The spread between the session’s top winner and its largest loser ran to more than 43 percentage points, a level of dispersion that reflects a market in which individual stock selection is mattering more than index-level direction.
The S&P 500’s 52-week range runs from 6,316.91 to 7,816.70. Tuesday’s close of 7,677.25 leaves the index roughly 139 points below the annual high and equally far above the low, placing it symmetrically in the upper half of that range. That arithmetic does not provide direction. What it provides is a sense of where support and resistance sit, and how much distance remains between the current level and the test of the year’s high.
What Tuesday did not resolve: whether Warsh signals a shift in Fed guidance Friday, whether DICK’S Sporting Goods points to broader consumer discretionary strain or an isolated integration error, and whether Moderna’s Phase 3 readout translates into a durable rerating of mRNA oncology assets or a single-session move that fades as trial details are absorbed. Those questions do not close at the bell.
Related Posts
